A Comparative Proteomic Analysis of Erinacine A’s Inhibition of Gastric Cancer Cell Viability and Invasiveness | Zendy

HsingChun Kuo | Zendy; YurRen Kuo | Zendy; Kam-Fai Lee | Zendy; MengChiao Hsieh | Zendy; Cheng-Yi Huang | Zendy; YungYu Hsieh | Zendy; KoChao Lee | Zendy; HsiangLan Kuo | Zendy; LiYa Lee | Zendy; Wanping Chen | Zendy; ChihCheng Chen | Zendy; ShuiYi Tung | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Comparative Proteomic Analysis of Erinacine A’s Inhibition of Gastric Cancer Cell Viability and Invasiveness

Author(s) -

HsingChun Kuo,

YurRen Kuo,

Kam-Fai Lee,

MengChiao Hsieh,

Cheng-Yi Huang,

YungYu Hsieh,

KoChao Lee,

HsiangLan Kuo,

LiYa Lee,

Wanping Chen,

ChihCheng Chen,

ShuiYi Tung

Publication year - 2017

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000480338

Subject(s) - propidium iodide , protein kinase b , viability assay , apoptosis , biology , annexin , signal transduction , cell growth , microbiology and biotechnology , cancer research , cancer cell , pi3k/akt/mtor pathway , fas ligand , programmed cell death , chemistry , cancer , biochemistry , genetics

Background / Aims: Erinacine A, isolated from the ethanol extract of the Hericium erinaceus mycelium, has been demonstrated as a new alternative anticancer medicine. Drawing upon current research, this study presents an investigation of the molecular mechanism of erinacine A inhibition associated with gastric cancer cell growth.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research